Table 1.

Association of FXR with clinicopathological data from esophageal adenocarcinoma patients (N = 59)

	N	FXR Association		P-value*
		High	Low
Gender
Male	51	42	9
Female	8	6	2	0.42
Age (yrs)
< 65	27	21	6
≥ 65	32	27	5	0.25
Tumor stage
I–II	17	11	6
III–IV	42	37	5	0.018
Lymph node metastasis
+	48	41	7
−	11	7	4	0.047
Distant metastasis
+	14	12	2
−	45	36	9	0.31
Tumor differentiation
M to W	22	17	5
P	35	30	5	0.20
N/A	2	1	1
Tumor size
≤ 3 cm	13	8	5
> 3 cm	46	40	6	0.018

^*χ² test.

M, medium; W, well; P, poorly; N/A, data not available